Last update 24 May 2025

ALD-101

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms
ALD 101, ALD101
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Nervous System DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication-
Inactive Indication
AdrenoleukodystrophyCanavan DiseaseFucosidosis+ [10]
Originator Organization
Aldagen, Inc.Aldagen, Inc.
Active Organization-
Inactive Organization
Aldagen, Inc.Aldagen, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ALD-101
NCT00654433
/ TerminatedPhase 3
A Phase III Trial of ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transplantation (UCBT) in Patients With Inborn Errors of Metabolism
100 Clinical Results associated with ALD-101
Login to view more data
100 Translational Medicine associated with ALD-101
Login to view more data
100 Patents (Medical) associated with ALD-101
Login to view more data
100 Deals associated with ALD-101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AdrenoleukodystrophyPhase 3
United States
Aldagen, Inc.Aldagen, Inc.
01 Mar 2008
Canavan DiseasePhase 3
United States
Aldagen, Inc.Aldagen, Inc.
01 Mar 2008
FucosidosisPhase 3
United States
Aldagen, Inc.Aldagen, Inc.
01 Mar 2008
Leukodystrophy, Globoid CellPhase 3
United States
Aldagen, Inc.Aldagen, Inc.
01 Mar 2008
Leukodystrophy, MetachromaticPhase 3
United States
Aldagen, Inc.Aldagen, Inc.
01 Mar 2008
MucolipidosesPhase 3
United States
Aldagen, Inc.Aldagen, Inc.
01 Mar 2008
Mucopolysaccharidosis IPhase 3
United States
Aldagen, Inc.Aldagen, Inc.
01 Mar 2008
Mucopolysaccharidosis IIPhase 3
United States
Aldagen, Inc.Aldagen, Inc.
01 Mar 2008
Mucopolysaccharidosis VIPhase 3
United States
Aldagen, Inc.Aldagen, Inc.
01 Mar 2008
Niemann-Pick DiseasesPhase 3
United States
Aldagen, Inc.Aldagen, Inc.
01 Mar 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free